ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Update

Posted by Defense World Staff on Feb 13th, 2026

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report) was the recipient of a large increase in short interest in January. As of January 30th, there was short interest totaling 21,029 shares, an increase of 99.1% from the January 15th total of 10,560 shares. Based on an average daily trading volume, of 18,168 shares, the short-interest ratio is currently 1.2 days. Approximately 7.0% of the company’s stock are sold short. Approximately 7.0% of the company’s stock are sold short. Based on an average daily trading volume, of 18,168 shares, the short-interest ratio is currently 1.2 days.

ProShares UltraShort Nasdaq Biotechnology Stock Up 1.9%

Shares of ProShares UltraShort Nasdaq Biotechnology stock opened at $8.91 on Friday. ProShares UltraShort Nasdaq Biotechnology has a 52-week low of $8.37 and a 52-week high of $25.87. The company has a 50-day simple moving average of $9.16 and a two-hundred day simple moving average of $11.44.

ProShares UltraShort Nasdaq Biotechnology Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 31st. Shareholders of record on Wednesday, December 24th were paid a dividend of $0.1026 per share. This represents a $0.41 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date was Wednesday, December 24th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Csenge Advisory Group acquired a new stake in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 12,421 shares of the company’s stock, valued at approximately $163,000. Csenge Advisory Group owned 6.54% of ProShares UltraShort Nasdaq Biotechnology at the end of the most recent reporting period.

About ProShares UltraShort Nasdaq Biotechnology

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.